Bakels V, van Oostveen J W, Preesman A H, Meijer C J, Willemze R
Department of Dermatology, Free University Hospital, Amsterdam, Netherlands.
J Clin Pathol. 1998 Feb;51(2):154-8. doi: 10.1136/jcp.51.2.154.
Differentiation between actinic reticuloid and cutaneous T cell lymphoma can be extremely difficult. Demonstration of clonal T cell receptor (TCR) gene rearrangements has been suggested as a potential diagnostic criterion, but the results obtained thus far have been conflicting. This study investigated whether TCR gamma gene rearrangement analysis, using polymerase chain reaction (PCR) in combination with denaturing gradient gel electrophoresis (DGGE) and immunohistochemistry, can serve as a diagnostic criterion.
PCR/DGGE was performed on skin, peripheral blood mononuclear cells, and/or lymph nodes of seven patients with actinic reticuloid, 11 patients with Sézary syndrome, and 15 patients with a benign form of erythroderma. The results of PCR/DGGE and Southern blot analysis of TCR beta gene rearrangements were compared. In addition, CD4:CD8 ratios in skin and peripheral blood samples were investigated.
Clonal T cell populations were detected in 19 of 21 samples obtained from patients with Sézary syndrome but were not detected in any of the 12 samples from patients with actinic reticuloid. Clonal T cells were detected in the peripheral blood of only one of 15 patients with a benign form of erythroderma. PCR/DGGE and Southern blot analysis gave concordant results in 28 of 29 samples. Immunophenotypic analysis demonstrated increased proportions of CD8+ T cells in skin (seven of seven cases) and peripheral blood (four of seven cases) of patients with actinic reticuloid.
The results of this study demonstrate that gene rearrangement analysis, in combination with immunohistochemistry, may be an important adjunct in differentiating between actinic reticuloid and cutaneous T cell lymphoma. In patients suspected of having actinic reticuloid, application of both techniques is recommended.
光化性类网状细胞增生症与皮肤T细胞淋巴瘤的鉴别极为困难。有研究提出克隆性T细胞受体(TCR)基因重排的检测可作为一项潜在的诊断标准,但目前所获结果相互矛盾。本研究调查了采用聚合酶链反应(PCR)联合变性梯度凝胶电泳(DGGE)及免疫组化进行TCRγ基因重排分析是否可作为一项诊断标准。
对7例光化性类网状细胞增生症患者、11例 Sézary综合征患者及15例良性红皮病患者的皮肤、外周血单个核细胞及/或淋巴结进行PCR/DGGE检测。将PCR/DGGE结果与TCRβ基因重排的Southern印迹分析结果进行比较。此外,还对皮肤和外周血样本中的CD4:CD8比值进行了研究。
从Sézary综合征患者获取的21份样本中有19份检测到克隆性T细胞群体,而光化性类网状细胞增生症患者的12份样本中均未检测到。15例良性红皮病患者中仅有1例在外周血中检测到克隆性T细胞。29份样本中有28份的PCR/DGGE结果与Southern印迹分析结果一致。免疫表型分析显示,光化性类网状细胞增生症患者皮肤(7例中的7例)和外周血(7例中的4例)中CD8+T细胞比例增加。
本研究结果表明,基因重排分析联合免疫组化可能是鉴别光化性类网状细胞增生症与皮肤T细胞淋巴瘤的一项重要辅助手段。对于疑似光化性类网状细胞增生症的患者,建议同时应用这两种技术。